We are unfortunately unable to allow patients to attend Acute & General Medicine

Hands-On Training G - Sponsored by AstraZeneca

Subpage Hero


Hands-on Training G:

Day 1 (Tuesday, 14th November)

A Practical Guide to the Acute Management of DOAC-related Major Bleeds

Time: 10.00-10.45, 11.00-11.45, 12.00-12.45

This promotional workshop will provide a practical guide on the use of Ondexxya®(andexanet alfa) to support the acute management of patients on apixaban or rivaroxaban who present with a life-threatening bleed. The session will include an overview on the dosing and administration of the product as well as guidance on storage and integrating the use of Ondexxya within pathways. 

This is a promotional workshop intended for UK healthcare professionals which has been organised and funded by AstraZeneca. 

Ondexxya® has conditional approval for adult patients treated with apixaban or rivaroxaban when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

Great Britain Prescribing Information

Northern Ireland Prescribing Information

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033



Valentino Oriolo, FESC
Consultant Practitioner, UEC, UHBW
Advanced Practice Lead, UHBW
Co-Lead SIM Centre, UHBW
Cardiology Credential Lead, RCP
Supervision and Assessment Lead, AIM, EM, NHS England
Education Committee Co-Chair, ACNAP (ESC)
Associate Senior Lecturer CVS Pharmacology, UWE

GB-49818 | November 2023


Hands-On Training Sessions are only available for registered delegates. You can book your pass by clicking here. 

Book your sessions via the app - Download Here

Newsletter Sign Up